ImmunologybioRxivPreprint
Monovalent and trivalent VSV-based COVID-19 vaccines elicit potent neutralizing antibodies and immunodominant CD8+ T cells against diverse SARS-CoV-2 variants
K. A. Parham, G. N. Kim, N. Saeedian…·R. M. Troyer
This study evaluates rVSV-based vaccines against SARS-CoV-2 variants, showing potent neutralizing antibodies and CD8+ T cell responses across multiple variants.
DOI 10.1101/2022.07.19.500626